Feb 26, 2018 4:05 pm EST VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer
Feb 5, 2018 8:30 am EST VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.
Jan 3, 2018 8:30 am EST VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone
Nov 10, 2017 7:30 am EST Singapore Volition signs Memorandum of Understanding with the National Taiwan University to Conduct Two Large Clinical Studies
Nov 9, 2017 4:05 pm EST VolitionRx Limited Announces Third Quarter 2017 Financial Results and Business Update
Nov 2, 2017 8:30 am EDT VolitionRx Limited Schedules Third Quarter 2017 Earnings Conference Call and Business Update
